Literature DB >> 10486607

Functional capacity of the cirrhotic liver after partial hepatectomy in the rat.

M Hashimoto1, G Watanabe.   

Abstract

BACKGROUND: Posthepatectomy liver insufficiency is one of the most serious problems associated with a major hepatic resection, especially in the cirrhotic liver, which has less functional reserve than the normal liver. Evaluation of morphologic liver regeneration is important in cirrhotic rats, as well as in the normal liver, and assessment of functional capacity in cirrhosis is clinically important for preventing hepatic insufficiency of the remnant liver after hepatectomy.
METHODS: We evaluated the functional capacity of the cirrhotic liver induced by carbon tetrachloride in rats and studied the correlation between morphologic and functional restoration of the liver after partial hepatectomy in comparison with healthy rats. Morphologic restoration of the liver after hepatectomy was evaluated on the basis of remnant liver weight, proliferating cell nuclear antigen labeling index, and the DNA content of the regenerating liver. Functional restoration was evaluated by the indocyanine green disappearance rate and serum aminopyrine clearance.
RESULTS: Morphologic restoration in cirrhotic rats was delayed in comparison with healthy rats. Although functional capacity in the cirrhotic rats was diminished, functional restoration was advanced after a two-thirds hepatectomy, in comparison with morphologic restoration.
CONCLUSIONS: Functional restoration in cirrhotic rats after partial hepatectomy is advanced in comparison with morphologic restoration.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10486607

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  6 in total

1.  Preoperative galactose elimination capacity predicts complications and survival after hepatic resection.

Authors:  Claudio A Redaelli; Jean-François Dufour; Markus Wagner; Martin Schilling; Jürg Hüsler; Lukas Krähenbühl; Markus W Büchler; Jürg Reichen
Journal:  Ann Surg       Date:  2002-01       Impact factor: 12.969

2.  1,4-Bis[2-(3,5-dichloropyridyloxy)]benzene induces substantial hyperplasia in fibrotic mouse liver.

Authors:  Edina Bugyik; Katalin Dezso; Eszter Turányi; Kinga Szurián; Sándor Paku; Peter Nagy
Journal:  Int J Exp Pathol       Date:  2012-01-14       Impact factor: 1.925

3.  Hepatocyte growth factor and c-Met inhibition by hepatic cell hypoxia: a potential mechanism for liver regeneration failure in experimental cirrhosis.

Authors:  Christophe Corpechot; Veronique Barbu; Dominique Wendum; Nicolas Chignard; Chantal Housset; Raoul Poupon; Olivier Rosmorduc
Journal:  Am J Pathol       Date:  2002-02       Impact factor: 4.307

4.  Hepatocyte growth factor gene therapy accelerates regeneration in cirrhotic mouse livers after hepatectomy.

Authors:  F Xue; T Takahara; Y Yata; Y Kuwabara; E Shinno; K Nonome; M Minemura; S Takahara; X Li; E Yamato; A Watanabe
Journal:  Gut       Date:  2003-05       Impact factor: 23.059

5.  Effect of granulocyte-macrophage colony-stimulating factor on hepatic regeneration after 70% hepatectomy in normal and cirrhotic rats.

Authors:  A Eroğlu; S Demirci; H Akbulut; N Sever; S Demirer; A E Unal
Journal:  HPB (Oxford)       Date:  2002       Impact factor: 3.647

6.  Evaluation of liver regeneration and post-hepatectomy liver failure after hemihepatectomy in patients with hepatocellular carcinoma.

Authors:  Wen-Feng Gong; Jian-Hong Zhong; Zhan Lu; Qiu-Ming Zhang; Zhi-Yuan Zhang; Chang-Zhi Chen; Xu Liu; Liang Ma; Zhi-Ming Zhang; Bang-De Xiang; Le-Qun Li
Journal:  Biosci Rep       Date:  2019-08-23       Impact factor: 3.840

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.